Deutsche Bank Aktiengesellschaft Lowers agilon health (NYSE:AGL) Price Target to $27.00

agilon health (NYSE:AGL – Get Rating) had its price objective decreased by Deutsche Bank Aktiengesellschaft from $28.00 to $27.00 in a research note published on Monday, The Fly reports.

AGL has been the subject of a number of other research reports. Stifel Nicolaus increased their target price on shares of agilon health from $29.00 to $32.00 in a research report on Wednesday, May 10th. Guggenheim raised their price objective on shares of agilon health from $21.00 to $30.00 and gave the stock a buy rating in a research report on Monday, March 6th. Wells Fargo & Company raised their price objective on shares of agilon health from $22.00 to $28.00 in a research report on Thursday, March 16th. Finally, Truist Financial raised their price objective on shares of agilon health from $29.00 to $35.00 and gave the stock a buy rating in a research report on Monday, April 17th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, agilon health has a consensus rating of Moderate Buy and an average target price of $31.13.

agilon health Stock Down 1.4 %

Shares of NYSE AGL opened at $23.81 on Monday. The firm has a market cap of $9.87 billion, a PE ratio of -108.23 and a beta of 1.13. The company has a 50 day simple moving average of $25.64 and a 200 day simple moving average of $21.43. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.71 and a quick ratio of 2.71. agilon health has a 1 year low of $15.00 and a 1 year high of $29.44.

agilon health (NYSE:AGL – Get Rating) last released its earnings results on Wednesday, March 1st. The company reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.06). The firm had revenue of $689.77 million for the quarter, compared to analyst estimates of $666.32 million. agilon health had a negative net margin of 3.93% and a negative return on equity of 9.33%. On average, research analysts forecast that agilon health will post -0.08 EPS for the current year.

Insider Activity at agilon health

In related news, insider Veeral Desai sold 4,500 shares of agilon health stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $26.15, for a total value of $117,675.00. Following the completion of the sale, the insider now owns 299,585 shares of the company’s stock, valued at approximately $7,834,147.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other agilon health news, insider Veeral Desai sold 4,500 shares of the firm’s stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $26.15, for a total transaction of $117,675.00. Following the transaction, the insider now directly owns 299,585 shares in the company, valued at approximately $7,834,147.75. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Benjamin Shaker sold 28,555 shares of the firm’s stock in a transaction on Wednesday, February 15th. The shares were sold at an average price of $23.37, for a total value of $667,330.35. Following the transaction, the insider now owns 25,625 shares in the company, valued at $598,856.25. The disclosure for this sale can be found here. In the last 90 days, insiders sold 74,743 shares of company stock valued at $1,924,103. 3.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On agilon health

A number of hedge funds have recently made changes to their positions in the business. Cubist Systematic Strategies LLC raised its stake in shares of agilon health by 86.9% during the 1st quarter. Cubist Systematic Strategies LLC now owns 399,182 shares of the company’s stock worth $9,481,000 after purchasing an additional 185,623 shares during the period. Bayesian Capital Management LP bought a new stake in shares of agilon health during the 1st quarter worth $569,000. Deutsche Bank AG raised its stake in shares of agilon health by 19.8% during the 1st quarter. Deutsche Bank AG now owns 1,198,153 shares of the company’s stock worth $28,456,000 after purchasing an additional 197,655 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of agilon health by 222.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,304,003 shares of the company’s stock worth $54,721,000 after purchasing an additional 1,590,432 shares during the period. Finally, Macquarie Group Ltd. bought a new stake in shares of agilon health during the 1st quarter worth $1,162,000.

agilon health Company Profile

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.